Validation of Simultaneous Quantitative Method of HIV Protease Inhibitors Atazanavir, Darunavir and Ritonavir in Human Plasma by UPLC-MS/MS
Objectives. HIV protease inhibitors are used in the treatment of patients suffering from AIDS and they act at the final stage of viral replication by interfering with the HIV protease enzyme. The paper describes a selective, sensitive, and robust method for simultaneous determination of three protea...
Saved in:
Main Authors: | Tulsidas Mishra, Pranav S. Shrivastav |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1155/2014/482693 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development and validation of a UPLC-MS method for determination of atazanavir sulfate by the “analytical quality by design” approach
by: Saha Chandni, et al.
Published: (2020-03-01) -
Pharmacokinetic Analysis of Diosgenin in Rat Plasma by a UPLC-MS/MS Approach
by: Pei Liu, et al.
Published: (2022-01-01) -
Rapid, Validated UPLC-MS/MS Method for Determination of Glibenclamide in Rat Plasma
by: Mohd Aftab Alam, et al.
Published: (2018-01-01) -
Simultaneous Quantification of Aspirin, Its Metabolite Salicylic Acid, and Salvianolic Acid B in Human Plasma Using UPLC-MS/MS
by: Weiyi Cao, et al.
Published: (2021-01-01) -
Pharmacokinetic Comparisons of Mangiferin and Mangiferin Monosodium Salt in Rat Plasma by UPLC-MS/MS
by: Hongbin Guo, et al.
Published: (2019-01-01)